# Jennifer Anne Brown

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jennifer-anne-brown/

## Facts

| Field | Value |
| --- | --- |
| Citations | 357 |
| Field | HIV/AIDS Research and Interventions |
| h-index | 13 |
| i10-index | 14 |
| Last Known Institution | University of Basel |
| OpenAlex ID | https://openalex.org/A5035318549 |
| ORCID iD | 0000-0003-1874-6153 |
| Works | 55 |

## Researcher papers

- [Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)](https://scholariq.org/papers/viral-suppression-after-transition-from-nonnucleoside-reverse-transcriptase/)
- [Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho](https://scholariq.org/papers/emergence-of-acquired-dolutegravir-resistance-in-treatment-experienced-people/)
- [Relationship of Hepatitis C Genotype 1 NS5A Sequence Mutations to Early Phase Viral Kinetics and Interferon Effectiveness](https://scholariq.org/papers/relationship-of-hepatitis-c-genotype-1-ns5a-sequence-mutations-to-early-phase/)
- [HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: a multicentre cohort study](https://scholariq.org/papers/hiv-viral-suppression-in-children-and-adolescents-2-years-after-transition-to/)
- [Psychologie der industriellen Leistung](https://scholariq.org/papers/psychologie-der-industriellen-leistung/)
- [Engagement in Care, Viral Suppression, Drug Resistance, and Reasons for Nonengagement After Home-Based Same-Day Antiretroviral Therapy Initiation in Lesotho: A Two-Year Follow-up of the CASCADE Trial](https://scholariq.org/papers/engagement-in-care-viral-suppression-drug-resistance-and-reasons-for/)
- [Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho](https://scholariq.org/papers/two-year-outcomes-of-treatment-experienced-adults-after-programmatic/)
- [Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial](https://scholariq.org/papers/effectiveness-of-a-peer-educator-coordinated-preference-based-differentiated/)
- [Treatment Outcomes After Offering Same-Day Initiation of Human Immunodeficiency Virus Treatment—How to Interpret Discrepancies Between Different Studies](https://scholariq.org/papers/treatment-outcomes-after-offering-same-day-initiation-of-human-immunodeficiency/)
- [Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial](https://scholariq.org/papers/extensive-drug-resistance-during-low-level-hiv-viraemia-while-taking-nnrti-based/)
- [Examining Sociodemographic Factors Related to Autism Screening Rates of Children in Early Intervention](https://scholariq.org/papers/examining-sociodemographic-factors-related-to-autism-screening-rates-of-children/)

## Researcher topics

- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)
- [Mobile Health and mHealth Applications](https://scholariq.org/topics/mobile-health-and-mhealth-applications/)

## Researcher university

- [University of Basel](https://scholariq.org/institutions/university-of-basel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.